BlackRock »

Brainstorm Cell Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $87k 378k 0.23

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Brainstorm Cell Therapeutics

Armistice Capital
Vanguard Group
Geode Capital Management
BlackRock
BlackRock
Liberty Wealth Management
Weaver Consulting Group
Susquehanna International
State Street Corporation
Northern Trust
Two Sigma Securities
Raymond James & Associates
Tower Research Capital
Jmac Enterprises
Wells Fargo & Company

View all funds holding Brainstorm Cell Therapeutics